arrow
P

Paolo Calabrò

university of campania luigi vanvitelli
H指数:71
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Visceral Adipose Tissue Measured by DXA, Prevalent Cardiovascular Disease, and Mortality in US Adults: Cross-Sectional and Prospective Analyses from NHANES 2011–2018

通过DXA测量的内脏脂肪组织、心血管疾病患病率及美国成年人死亡率:基于NHANES 2011–2018的横断面和前瞻性分析

2026-10-210
OAAI
Frequency and Prognosis of Alternative Definitions of Occlusion Myocardial Infarction Across the Whole Spectrum of Acute Coronary Syndromes

不同定义的闭塞心肌梗死在急性冠脉综合征全谱中的发生频率与预后

2026-10-120
PRE
Early outcomes of the Octapro balloon-expandable transcatheter heart valve in an unrestricted cohort of patients with aortic valve stenosis: the MyPro registry

奥克塔普罗球囊扩张式经导管心脏瓣膜在主动脉瓣狭窄患者非限制性队列中的早期结果:MyPro登记研究

2026-10-060
PRE
Personalised antiplatelet therapy during elective percutaneous coronary intervention in patients with chronic coronary syndrome: An international journal of cardiology expert consensus statement

慢性冠状动脉综合征患者择期经皮冠状动脉介入治疗期间个体化抗血小板治疗:国际心脏病学杂志专家共识声明

2026-09-290
OA
“Lipoprotein(a) Across Coronary Plaque Phenotypes from High-Risk to Layered Plaque: An OCT Analysis from the RELACS Registry”

“脂蛋白(a)在从高危斑块到分层斑块的不同冠状动脉斑块表型中的分布:RELACS注册研究的光学相干断层扫描分析”

2026-09-030
PRE
Educational professional activities for enhancing heart failure guidelines implementation: data from the Optimization of Therapy in the Italian Management of Heart Failure (OpTIMa-HF) Registry

针对心力衰竭指南实施的教育专业活动:意大利心力衰竭管理中的优化治疗(OpTIMa-HF)登记研究数据

2026-08-040
OA
Standard clinical and stress electrocardiogram variables to exclude left main and left main-equivalent disease: the MASTER study

标准临床和应激心电图变量以排除左主干及左主干等价病变:MASTER研究

2026-07-230
OAAI
Diagnostic and therapeutic inertia for LDL cholesterol management of consecutively verified patients with acute myocardial infarction

连续确诊的急性心肌梗死患者低密度脂蛋白胆固醇管理的诊断和治疗惰性

2026-06-200
OA
Optimal Antithrombotic Regimens Across Atherosclerotic Vascular Beds: Toward Mechanism and Risk-Oriented Strategies

动脉粥样硬化血管床中的最佳抗血栓方案:面向机制与风险导向的策略

2026-04-060
OAAI
Prognostic impact of high-risk plaque morphology and impaired physiology in untreated non-culprit coronary lesions: a systematic review and meta-analysis

高危斑块形态和受损生理对未处理非责任冠状动脉病变的预后影响:一项系统评价和荟萃分析

2026-03-030
OA
Optimal Medical Therapy Targeting Metabolic Status for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention
2026-01-310
OAAI
Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention

针对接受经皮冠状动脉介入治疗患者的二级预防,以脂质和炎症为目标的最佳药物治疗

2025-11-240
OAAI